Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss
Home>Topics>>ACRX Falls On Financing, Creating Opportunity Ahead Of Phase III Data

ACRX Falls On Financing, Creating Opportunity Ahead Of Phase III Data

Long Investing Ideas from Seeking Alpha

Thu, 6 Dec 2012

By PropThink : By Jake King AcelRx ( ACRX ) will issue and sell up to 11.5M shares of common stock in the coming weeks, just months ahead of a pivotal period for the maker of post-operative analgesics. AcelRx expects to report the results of two Phase III trials for its lead candidate the ...

Read the rest of this article on Long Investing Ideas from Seeking Alpha

Content Partners
Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K. Switzerland India Finland
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.